| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/26/2007 | US20070093505 2,3-Substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators |
| 04/26/2007 | US20070093484 3-Substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators |
| 04/26/2007 | US20070093483 Use of derivatives of 2, 4-dihydro-[1,2,4] triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo) |
| 04/26/2007 | US20070093481 Benzopyran derivatives substituted with a thioxobenzoxazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containingthem |
| 04/26/2007 | US20070093479 6-chloro-N-(3,3-dimethylbutyl)-5-phenyl-1H-indazol-3-amine; for treating neurodegenerative diseases such as Alzheimer's, fronto-parietal dementia, Pick's disease, Parkinson's disease, type II diabetes, corticobasal degeneration, in which phosphorylation of the tau protein is observed |
| 04/26/2007 | US20070093478 Novel mycobacterial inhibitors |
| 04/26/2007 | US20070093477 Alpha2C adrenoreceptor agonists |
| 04/26/2007 | US20070093472 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors xa and viia for the treatment of thromboses |
| 04/26/2007 | US20070093467 2-(4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-1-[4-(4-fluorobenzyl),4-hydroxypiperidin-1-yl]ethanone; potent chemokine receptor antagonists; antiinflammatory agents; immunotherapy; rheumatic diseases; antiarthritic agents; transplant rejection; multiple sclerosis |
| 04/26/2007 | US20070093454 sodium channel modulators, such as Isobutyl 4-(6-(2-hydroxyphenyl)pyrimidin-4-yl)piperazine-1-carboxylate, used as analgesics |
| 04/26/2007 | US20070093453 Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
| 04/26/2007 | US20070092954 Production of polyketides |
| 04/26/2007 | DE102005050892A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 04/26/2007 | DE102005050408A1 Neue Vanilloidrezeptor-Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments |
| 04/26/2007 | CA2625877A1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 04/26/2007 | CA2625762A1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 04/26/2007 | CA2624166A1 Inhibitors of viral replication |
| 04/25/2007 | EP1777225A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776359A2 Piperidine derivatives as renin inhibitors |
| 04/25/2007 | EP1776337A2 Benzyloxy derivatives as maob inhibitors |
| 04/25/2007 | EP1631296B1 2,3,4,5-tetrahydrobenzo¬f|¬1,4|oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease |
| 04/25/2007 | EP1537100B1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 04/25/2007 | EP1408950B1 Methods of treating cytokine mediated diseases |
| 04/25/2007 | EP1315710B1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1209151B1 4-substituted piperidine derivatives |
| 04/25/2007 | EP1024138B1 Pyrazole derivatives |
| 04/25/2007 | CN1953976A Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain |
| 04/25/2007 | CN1953974A Pyrimidine derivatives for the treatment of abnormal cell growth |
| 04/25/2007 | CN1953967A Purification of progesterone receptor modulators |
| 04/25/2007 | CN1953965A Novel cis-imidazolines |
| 04/25/2007 | CN1951918A Substituted pyridine herbicides |
| 04/25/2007 | CN1312148C Isochroman compounds for treatment of CNS disorders |
| 04/25/2007 | CN1312136C Triazole derivatives as tachykinin receptor antagonists |
| 04/24/2007 | US7208602 N-sulfonyl- azetidines, pyrrolidines, piperidines and hexamethylenimines; treatment and prevention of Alzheimer's Disease and other diseases relating to the deposition of amyloid protein. |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208505 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group |
| 04/24/2007 | US7208497 Substituted piperazines and diazepanes |
| 04/24/2007 | US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 04/24/2007 | CA2307820C Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/24/2007 | CA2197793C New multimerizing agents |
| 04/24/2007 | CA2194503C 2-[(dihydro)pyrazol-3'-yloxymethylene]anilides, their preparation and their use |
| 04/19/2007 | WO2007044515A1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 04/19/2007 | WO2007044491A1 N-substituted pyridinone or pyrimidinone compounds useful as soluble epoxide hydrolase inhibitors |
| 04/19/2007 | WO2007044490A2 Process for making heteroaryl amine intermediate compounds |
| 04/19/2007 | WO2007043677A1 Hydrazide compound and pesticidal use of the same |
| 04/19/2007 | WO2007043653A1 Benzimidazole-5-carboxamide derivative |
| 04/19/2007 | WO2007043457A1 Triarylcarboxylic acid derivative |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007042906A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 04/19/2007 | WO2007042878A1 Novel heterocyclic analogs of biphenyl ethers |
| 04/19/2007 | WO2007042816A1 Benzoxazoles useful in the treatment of inflammation |
| 04/19/2007 | WO2007042544A2 Imidazole derivatives and their use for modulating the gabaa receptor complex |
| 04/19/2007 | WO2007042420A1 Isoxazole derivatives |
| 04/19/2007 | WO2007042325A1 Antibacterial active 5-chinolin derivative |
| 04/19/2007 | WO2007020050A3 Bicyclic bisamide derivatives and use thereof as insecticides |
| 04/19/2007 | WO2007020050A2 Bicyclic bisamide derivatives and use thereof as insecticides |
| 04/19/2007 | WO2007017546A3 Method of obtaining tryptamine derivatives |
| 04/19/2007 | WO2007006534A3 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 04/19/2007 | WO2006116157A3 Dipeptidyl peptidase-iv inhibitors |
| 04/19/2007 | WO2006034317A3 Chemical compounds |
| 04/19/2007 | WO2006033005A8 Thrombopoietin receptor agonists |
| 04/19/2007 | WO2005097783A8 Thiocarbamoylprolines |
| 04/19/2007 | US20070088159 Hydroxyalkyl cyclic diamine compounds |
| 04/19/2007 | US20070088062 N-[4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine; keratinization disorder such as rosacea, acne, and psoriasis; potent inhibitors of the retinoic acid-metabolism; show little or no endocrinological side-effects; |
| 04/19/2007 | US20070088060 highly active active agents from the structural class of the epothilones and epothilone derivatives with suitable linkers; to link these epothilone-linker conjugates to recognition units, such as, for example, monoclonal antibodies or fragments thereof, to form immune conjugates |
| 04/19/2007 | US20070088051 Indolinones and their use as antiproliferative agents |
| 04/19/2007 | US20070088044 Quinazoline derivatives as antitumor agents |
| 04/19/2007 | US20070088042 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 04/19/2007 | US20070088041 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals |
| 04/19/2007 | US20070088037 Cancer and fibrotic diseases |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088032 Processes for the Preparation of Benzoimidazole Derivatives |
| 04/19/2007 | US20070088028 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/19/2007 | US20070088026 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi |
| 04/19/2007 | US20070088016 5-substituted arylmethylidenyl (thio)xanthenes; hypotensive agents, antiinflammatory agents, antiarthritic agents; congestive heart failure |
| 04/19/2007 | DE102005049385A1 Imidazolderivate als Inhibitoren von TAFIa Imidazole derivatives as inhibitors of TAFIa |
| 04/19/2007 | DE102005048897A1 Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen Diacylindazol derivatives as inhibitors of lipases and phospholipases |
| 04/19/2007 | CA2625687A1 Antibacterial active 5-chinolin derivative |
| 04/19/2007 | CA2625301A1 Isoxazole derivatives |
| 04/19/2007 | CA2624307A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 04/19/2007 | CA2623768A1 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 04/19/2007 | CA2623759A1 Pyridopyrimidinone inhibitors of pim 1 and/or pim-3 |
| 04/19/2007 | CA2623202A1 Hydrazide compound and pesticidal use of the same |
| 04/19/2007 | CA2622755A1 Mek inhibitors and methods of their use |
| 04/19/2007 | CA2622754A1 N-substituted pyridinone or pyrimidinone compounds useful as soluble epoxide hydrolase inhibitors |
| 04/19/2007 | CA2621038A1 Triarylcarboxylic acid derivative |
| 04/19/2007 | CA2620899A1 Benzoxazoles useful in the treatment of inflammation |
| 04/18/2007 | EP1773828A1 Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 04/18/2007 | EP1773825A1 Dioxazinyl-substituted thienylsulphonylaminocarbonyl compounds |
| 04/18/2007 | EP1773824A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 04/18/2007 | EP1773823A1 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof |
| 04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 04/18/2007 | EP1773817A1 Substituted aryl-amine derivatives and methods of use |
| 04/18/2007 | EP1773810A1 New 4-benzylidene-piperidin derivatives |
| 04/18/2007 | EP1773805A1 Quinazolin-4-yl-piperidine and cinnolin-4-yl-piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 04/18/2007 | EP1773797A2 Aromatic compounds |
| 04/18/2007 | EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors |